While the frequency of CD8+ T cells increased in both mouse types from baseline up to fourteen days post tumour cell grafting and remained steady at ~10% of live cells after this, no statistically significant differences were seen between the mouse types (Figure 6a). Here, CD8A is linked to neoplasm.